Sinomenine, a pure
alkaloid extract from Sinomenium acutum, has anti-inflammatory and immunoregulatory functions. This study investigated the efficiency and the signalling pathways involved in the effect of
sinomenine on vascular smooth muscle cell (VSMC) dedifferentiation in response to
platelet-derived growth factor (
PDGF)-BB stimulation and
vascular injury. VSMCs were isolated from rat aorta and preincubated with
sinomenine before being stimulated with
PDGF-BB. WST and
BrdU incorporation assays were used to evaluate VSMC proliferation. Flow cytometric analysis was performed for testing the cell cycle progression. The cell migration of VSMCs were analysed using a Transwell system. The expression of VSMC specific genes and signalling
proteins were tested by Western blot. For the animal study, C57/BL6 mice were fed either normal rodent chow diets or
sinomenine chow diets that supplemented with 0.09 %
sinomenine (w/w) in the normal chows for 14 days before carotid artery wire injury.
PDGF-BB activated the dedifferentiation of VSMCs characterised by decreased expression of SMA, Smoothelin and SM22α. However,
sinomenine treatment preserved the dedifferentiation in response to
PDGF-BB. The activations of
mitogen-activated protein kinase extracellular signal-regulated kinases, Akt, GSK3β and STAT3 induced by
PDGF-BB were also inhibited in
sinomenine-treated VSMCs. In vivo evidence with wire-injured mice exhibited a reduction in neointimal area and an increase in smooth muscle-specific gene expression in the
sinomenine-treated group. In this study, we found that
sinomenine-suppressed VSMC phenotype switching induced by
PDGF-BB in vitro and neointimal formation in vivo. Therefore,
sinomenine is a potential candidate to be used in the treatment of vascular proliferative disease.